Medical devices, healthcare technology and the business of care
510(k) clearance · K243223

Multiple therapy aesthetic treatment device (BHS 202 UNYQUE)

Bh Group Us, LLC · Decision date Sep 22, 2026

MEDTECHLEDGER EXPLANATIONK243223

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 2026-09-22 for K243223, a traditional 510(k) submitted by Bh Group Us, LLC of Davie, Florida, for the Multiple therapy aesthetic treatment device (BHS 202 UNYQUE). The device falls under product code PBX, regulation 21 CFR 878.4400, in the General & Plastic Surgery specialty and review panel. The application was received 10/07/2024 and was not reviewed by a third party; it was not a combination product, and no predetermined change control plan was authorized.

SESE means the device was cleared as substantially equivalent to a predicate, not approved through the PMA pathway. The public record does not state which predicate device was used, the indications for use, the specific therapeutic components or energy modalities of the BHS 202 UNYQUE, or any clinical or performance data supporting the decision. Those details would sit in the linked summary document, which was not reviewed here.

The page also lists Diego Bazzurro as both applicant and correspondent contact, and shows a page update date of 10/26/2026.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 22, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K243223
Regulatory pathway
510(k) premarket notification
Product code
PBX
Decision code
SESE
Decision date
Sep 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Massager, Vacuum, Radio Frequency Induced Heat.

Product code
PBX
FDA device class
2

FDA decision timeline

  1. K243223 received

    Application receipt date recorded by FDA.

  2. K243223 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PBX

Product / regulatory recordCompanyPathwayDecision dateSource
Shenzhen Dongdixin Technology Co., Ltd.510(k) clearanceOct 13, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bh Group Us, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Davie, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records